
Uppsala Reports editor
@UMCGlobalSafety
Prof. Hervé Le Louët has resigned from his position as CEO of UMC due to family reasons. The recruitment process for next CEO starts immediately. During this interim period, Deputy CEO and former CFO, Birgitta Lindner, will serve as acting CEO, with full support from the Board.
During Le Louët’s tenure as CEO, UMC delivered impressive results. He helped drive forward necessary structural and strategic changes that will continue to be implemented. The Board thanks him for his work and wishes him all the best in the next phase of his career.
UMC’s dedicated and skilled staff will continue business as usual, pursuing their duties in line with the strategy and assignments set by the Board.
In January 2018, the national centre of Azerbaijan became the 130th full member of the WHO Programme for International Drug Monitoring - and there is much progress to report.
WHO programme / 23 June 2022
Luxembourg joined the WHO Programme for International Drug Monitoring in 2020, and being part of the network has already supported the growth of the pharmacovigilance department.
WHO programme / 04 May 2022
The National Health Regulatory Authority in Nicaragua is working across all sectors to improve medicines safety in their country.
WHO programme / 02 November 2022